Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21704964 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)
Condition: Choroidal Neovascularization
Intervention: Drug: Intravitreal injection ranibizumab
2 Recruiting Characterization of Pseudoxanthoma Elasticum
Condition: Pseudoxanthoma Elasticum
Intervention:

Study has passed its completion date and status has not been verified in more than two years.